Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma.

Full Abstract

No abstract is available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Jehanne, Mathilde (M); Mercier, Ghislaine (G); Doz, François (F);

Journal and publication information

Publication Type: Comment; Letter

Journal: Pediatric blood & cancer (Pediatr Blood Cancer), published in United States. (Language: eng)

Reference: 2009-Dec; vol 53 (issue 6) : pp 1162

Dates: Created 2009/09/16; Completed 2009/10/13;

PMID: 19479791, status: MEDLINE (last retrieval date: 10/13/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: Pediatr Blood Cancer. 2009 Sep;53(3):517. (PMID: 19484758)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Hearing Loss - chemically induced
Hearing Tests - methods
Humans
Retinoblastoma - complications; drug therapy

Associated Chemicals: Antineoplastic Agents (0) ; Carboplatin (41575-94-4)

These are the highest related articles currently in the database:

See 100+ related articles.